AU2002218280A1 - Process - Google Patents

Process

Info

Publication number
AU2002218280A1
AU2002218280A1 AU2002218280A AU1828002A AU2002218280A1 AU 2002218280 A1 AU2002218280 A1 AU 2002218280A1 AU 2002218280 A AU2002218280 A AU 2002218280A AU 1828002 A AU1828002 A AU 1828002A AU 2002218280 A1 AU2002218280 A1 AU 2002218280A1
Authority
AU
Australia
Prior art keywords
core
outer coating
exterior
openings
active agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002218280A
Inventor
Chi Leung Li
Luigi Martini
Philip Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Ltd
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd, SmithKline Beecham Corp filed Critical SmithKline Beecham Ltd
Publication of AU2002218280A1 publication Critical patent/AU2002218280A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23B—TURNING; BORING
    • B23B37/00—Boring by making use of ultrasonic energy

Abstract

An oral delivery device comprising a core which includes a pharmaceutically active agent, the core covered by an outer coating which includes one or more openings in the outer coating communicating from the exterior of the device toward the core, with a thin layer of the coating material over the core at the bottom of the opening.
AU2002218280A 2000-11-08 2001-11-02 Process Abandoned AU2002218280A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0027471.2A GB0027471D0 (en) 2000-11-08 2000-11-08 Processes
GB0027471.2 2000-11-08
PCT/EP2001/012729 WO2002038131A2 (en) 2000-11-08 2001-11-02 Process

Publications (1)

Publication Number Publication Date
AU2002218280A1 true AU2002218280A1 (en) 2002-05-21

Family

ID=9902924

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002218280A Abandoned AU2002218280A1 (en) 2000-11-08 2001-11-02 Process

Country Status (9)

Country Link
US (2) US7923027B2 (en)
EP (2) EP1333813B1 (en)
JP (1) JP4290981B2 (en)
AT (2) ATE428407T1 (en)
AU (1) AU2002218280A1 (en)
DE (2) DE60138428D1 (en)
ES (2) ES2256329T3 (en)
GB (1) GB0027471D0 (en)
WO (1) WO2002038131A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
BR0206062A (en) * 2001-09-28 2004-01-13 Mcneil Ppc Inc Dosage forms having an inner core and outer shell
US20040253312A1 (en) * 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
MY139719A (en) * 2002-02-12 2009-10-30 Glaxo Group Ltd Oral dosage form for controlled drug release
US8637512B2 (en) * 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
KR20050084605A (en) * 2002-09-28 2005-08-26 맥네일-피피씨, 인코포레이티드 Modified release dosage forms with two cores and an opening
GB0318824D0 (en) * 2003-08-11 2003-09-10 Glaxo Group Ltd Novel composition
US20050169994A1 (en) * 2003-11-25 2005-08-04 Burke Matthew D. Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7404708B2 (en) * 2004-12-07 2008-07-29 Mcneil-Ppc, Inc. System and process for providing at least one opening in dosage forms
CN101370483A (en) * 2005-12-30 2009-02-18 阿库布莱克科技公司 Dosage form for adhesion connection
US8273105B2 (en) * 2008-02-20 2012-09-25 Tyco Healthcare Group Lp Compound barb medical device and method
ES2525123T3 (en) 2008-06-04 2014-12-17 Colgate-Palmolive Company Implementation for oral care with cavitation system
US20100323015A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
KR20110052641A (en) * 2008-07-18 2011-05-18 베일언트 파마슈티컬스 인터내셔널 Modified release formulation and methods of use
US20100323016A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
EP3968966A1 (en) 2019-05-17 2022-03-23 GlaxoSmithKline Intellectual Property Development Ltd Matrix composition comprising (s)-5-benzyl-n-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4h-1,2,4-triazole-3-carboxamide

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1575050A1 (en) * 1966-01-12 1972-04-13 Misto Gen Equipment Co Ultrasonic fog generator
US4447235A (en) * 1981-05-07 1984-05-08 John M. Clarke Thoracentesis device
US4693886A (en) * 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
EP0303769A3 (en) * 1987-08-18 1989-10-25 Balzers Aktiengesellschaft Device for the transmission of rotary movements through a wall of a vacuum chamber
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
JPH02124251A (en) 1988-10-28 1990-05-11 Tanaka Kikinzoku Kogyo Kk Working method for small hole
US5123903A (en) * 1989-08-10 1992-06-23 Medical Products Development, Inc. Disposable aspiration sleeve for ultrasonic lipectomy
US5317932A (en) * 1992-02-28 1994-06-07 The Dow Chemical Company Sample probe
US5300046A (en) * 1992-03-30 1994-04-05 Symbiosis Corporation Thoracentesis sheath catheter assembly
US5674235A (en) * 1995-05-10 1997-10-07 Ultralase Technologies International Ultrasonic surgical cutting instrument
JPH1024491A (en) 1996-07-11 1998-01-27 Seidensha Denshi Kogyo Kk Ultrasonic machining apparatus
US6783662B2 (en) * 1999-03-18 2004-08-31 Exxonmobil Research And Engineering Company Cavitation enhanced liquid atomization
AU776314B2 (en) * 1999-07-20 2004-09-02 Merck & Co., Inc. Sustained release drug dispersion delivery device
CA2388159A1 (en) * 1999-10-29 2001-05-10 Merck & Co., Inc. Osmotic controlled release drug delivery device
US7708504B2 (en) * 2005-08-29 2010-05-04 Savannah River Nuclear Solutions, Llc Pneumatic conveyance apparatus and process

Also Published As

Publication number Publication date
US20110131754A1 (en) 2011-06-09
US7923027B2 (en) 2011-04-12
ATE314839T1 (en) 2006-02-15
EP1333813A2 (en) 2003-08-13
JP4290981B2 (en) 2009-07-08
US8765065B2 (en) 2014-07-01
DE60116530T2 (en) 2006-08-10
EP1655024B1 (en) 2009-04-15
US20040062806A1 (en) 2004-04-01
ATE428407T1 (en) 2009-05-15
WO2002038131A3 (en) 2002-09-12
ES2323879T3 (en) 2009-07-27
EP1333813B1 (en) 2006-01-04
EP1655024A1 (en) 2006-05-10
GB0027471D0 (en) 2000-12-27
WO2002038131A2 (en) 2002-05-16
JP2004512903A (en) 2004-04-30
DE60116530D1 (en) 2006-03-30
DE60138428D1 (en) 2009-05-28
ES2256329T3 (en) 2006-07-16

Similar Documents

Publication Publication Date Title
AU2002218280A1 (en) Process
USD481316S1 (en) Spray dispenser cap
AU2001261780A1 (en) Hydrophilic coating including dlc on substrate
USD458342S1 (en) Sprayer nozzle
CA2417511A1 (en) Dispensing device for dispensing scents
AU2002330164A1 (en) Modified release dosage forms
EP1542658A4 (en) Pharmaceutical compositions
CA2432203A1 (en) Sustained release drug delivery devices with multiple agents
CA2433032A1 (en) Sustained release drug delivery devices with coated drug cores
AU2002350246A1 (en) Providing content delivery during a call hold condition
AU2002220075A1 (en) Hydrophilic polymeric material for coating biosensors
WO2002072033A3 (en) Chronotherapeutic dosage forms containing glucocorticosteroid
AU2715701A (en) Wire, tube or catheter with hydrophilic coating
DE60044515D1 (en) azithromycin
AU2002366467A1 (en) Diffusion film, electrode having the diffusion film, and process for producing diffusion film
USD449002S1 (en) Bottle
WO2002102182A3 (en) Tongue and mouth stud for dispensing a substance
AU2001233278A1 (en) Dispenser with funnel overcap
AU2001258442A1 (en) Drug delivery device, especially for the delivery of levonorgestrel
WO2002005200A8 (en) A method, an apparatus, and a composition for customizing the combination of fragrances
AU2001263083A1 (en) Biologically active 4h-benzo(1,4)oxazin-3-ones
USD434784S (en) Portion of a sidewall of a nozzle for dispensing adhesives and sealants
MXPA03007272A (en) Medicament formulation containing a muscarinic agonist.
AU7687300A (en) Reference wafer for controlling accuracy and method for producing the same, aligner, and method for fabricating device
AU6481700A (en) Spinning nozzle, spinning nipple incorporating the spinning nozzle therein, and method for manufacturing both the same